PTEN protein loss by immunostaining: Analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients

Authors

Tamara L. Lotan, Johns Hopkins University
Bora Gurel, Johns Hopkins University
Siobhan Sutcliffe, Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis
David Esopi, Johns Hopkins University
Wennuan Liu, Wake Forest University
Jianfeng Xu, Wake Forest University
Jessica L. Hicks, Johns Hopkins University
Ben H. Park, Johns Hopkins University
Elizabeth Humphreys, Johns Hopkins University
Alan W. Partin, Johns Hopkins University
Misop Han, Johns Hopkins University
George J. Netto, Johns Hopkins University
William B. Isaacs, Johns Hopkins University
Angelo M. De Marzo, Johns Hopkins University

Document Type

Article

Journal

Clinical Cancer Research

Volume

17

Issue

20

Inclusive Pages

6563-73

Publication Date

2011

Recommended Citation

Lotan, Tamara L.; Gurel, Bora; Sutcliffe, Siobhan; Esopi, David; Liu, Wennuan; Xu, Jianfeng; Hicks, Jessica L.; Park, Ben H.; Humphreys, Elizabeth; Partin, Alan W.; Han, Misop; Netto, George J.; Isaacs, William B.; and De Marzo, Angelo M., "PTEN protein loss by immunostaining: Analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients" (2011). Biostatistics Faculty Publications. Paper 2.
Retrieved from https://digitalcommons.wustl.edu/biostats_pubs/2